The GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialization of its prescription medicines and vaccines in Nigeria.
Trending
- Nigeria rules out IMF loans as debt climbs, secures fresh multilateral financing
- Tinubu signs N68.32trn 2026 budget, extends 2025 capital spending to June
- PCN seals 598 drug outlets in Kaduna
- NBTE declares AI core to technical education
- Army arrests 15 suspected oil thieves in Lagos
- CBN, IFSB meet to deepen Islamic Finance Cooperation at IMF/World Bank meetings
- Cardoso advocates stronger capacity development for Africa at IMF/World Bank dialogue
- Dangote plans refinery IPO in 2026
